Background. Preemptive transplantation is associated with better survival and transplant outcomes than transplantation after dialysis has been started. The purpose of this study is to examine associations between candidate characteristics, likelihood of preemptive transplant, candidate survival and renal function (RF) at the time of listing. Methods. We looked at 57 677 solitary renal transplant candidates from the Scientific Registry of Transplant Recipients database listed prior to dialysis from 2000 to 2009. Using multivariable models, we measured associations between candidate characteristics, likelihood of preemptive transplantation, candidate survival and RF at listing. Results. Candidates with higher RF at listing were more likely to be male, Caucasian, diabetic, be a prior transplant recipient and have more education. Higher RF at listing was strongly associated with greater likelihood of receipt of preemptive transplant [adjusted odds ratio = 1.45, 95% confidence interval (CI) 1.38-1.51] and conferred a significant survival advantage [adjusted hazards ratio = 0.84, 95% CI 0.79-0.89, per 5 mL/min/1.73 m 2 ]. Conclusions. Patient characteristics associated with higher RF at listing suggest differences in access to care. Given that higher RF at the time of listing was also significantly associated with greater likelihood of preemptive transplantation and better survival prior to transplantation, our results suggest that listing at higher levels of RF may improve transplant candidate outcomes.
Introduction
Transplantation is the preferred treatment for end-stage renal disease because it is associated with superior clinical outcomes and improved quality of life when compared to other forms of renal replacement therapy (RRT) [1, 2] . Moreover preemptive transplantation, the receipt of a kidney by a patient prior to initiation of dialysis, is associated with better allograft and patient survival when compared with transplantation following maintenance dialysis [3] . The optimal timing for preemptive transplantation or preemptive listing with regard to renal function (RF) has not been clearly established. Prior observational studies have found that preemptive transplantation at a higher estimated glomerular filtration rate (eGFR) was not necessarily associated with better graft and patient survival [4, 5] . Neither observational studies [6, 7] nor a recent randomized trial [8] clearly define an optimal eGFR level for initiation of RRT.
However, observational studies have established that lower eGFR is an independent predictor of mortality risk in the general population [9, 10] . Therefore, lower eGFR at the time of listing may also be a risk factor for mortality in renal transplant candidates. Lower RF at listing could also possibly decrease the chance that a patient will receive a transplant prior to starting dialysis. The impact of RF on likelihood of a transplant may be particularly relevant in the USA, where the allocation algorithm for deceased donor kidneys includes time on the wait list beginning on the day of listing. Use of wait time for allocation has powerful ethical and clinical implications. In the USA, it is crucial for candidates to be listed as soon as they are eligible to maximize their chance of being allocated a deceased donor kidney.
Finally, several studies indicate that race, type of insurance, level of education and income can affect patient progress through the transplant process [11] [12] [13] [14] [15] . It is possible that patients with decreased access to care would be listed for a transplant later in the course of their renal disease and thus with a lower eGFR. So, we hypothesize that there is a direct association between patient characteristics previously linked to decreased access to care and lower eGFR at listing for transplantation.
The purposes of this analysis are [1] to describe patient factors associated with RF at the time of listing for a renal transplant [2] , to evaluate associations between RF at the time of listing, and [3] to evaluate whether RF at listing affects candidate survival among patients wait-listed prior to starting dialysis.
Materials and methods

Data sources
This study used data from the national Scientific Registry of Transplant Recipients (SRTR). The SRTR includes data on all donor, wait-listed candidates and transplant recipients in the USA, submitted by the members of the Organ Procurement and Transplantation Network, and has been described elsewhere [16] . This sample included adult kidneyonly transplant candidates wait-listed for a deceased donor transplant prior to initiation of dialysis between January 2000 and July 2009, for an initial sample size of 274 778 (Figure 1 ). The year 2000 was chosen because eGFR results were reported inconsistently on the United Network for Organ Sharing (UNOS) transplant forms prior to 2000. The study excluded 7926 patients <18 years old at the time of preemptive listing, 205 832 candidates already on dialysis at listing, and 2969 candidates with no eGFR or creatinine clearance (CrCl) available at listing. We excluded 374 candidates (1%) who were listed with eGFR >20 mL/ min/1.73 m 2 at listing due to UNOS policy that waiting time for transplantation is not accrued until eGFR is <20 mL/min/1.73 m 2 [17] . The eGFR used for the study was provided by the listing nephrologist on the UNOS Transplant Candidate Listing Sheet. The Listing Sheet does not record which equation was used to estimate glomerular filtration rate.
We incorporated US Census data to describe patients' zip code-level median income. The sample was also described geographically in terms of UNOS regions, as defined by US state groupings.
Statistical methods
The primary predictor variable for all models was eGFR at preemptive listing for solitary renal transplant. Multivariable linear regression was used to characterize associations between patient demographics, year of listing, laboratory values, comorbid conditions, prior transplant and RF at listing. Multivariable logistic regression was used to test the association between likelihood of a preemptive transplant and RF at the time of listing. This model was limited to those patients who received a transplant and also developed separately for living and deceased donor transplants. Candidate survival was assessed using Kaplan-Meier plots and multivariable Cox proportional hazard models from the time of listing, censored at last follow-up date or date of transplantation. Multivariable Cox models were used to assess associations between eGFR at listing and post-transplant graft and patient survival. Models were also stratified by candidate age, race, gender and diabetes as primary diagnosis, to test whether the impact of eGFR at preemptive listing on survival, differed between patient groups.
Hosmer-Lemeshow tests were used to evaluate goodness-of-fit of the logistic models, using an alpha level 0.05 threshold to assess poor model fit. Residual plot examinations tested assumptions of proportionality for the Cox models. All analyses were conducted in SAS (v.9.2; Cary, NC). The study was approved by the Cleveland Clinic Institutional Review Board. There were 23 332 patients without eGFR available at listing. For the primary analysis, we considered these patients missing at random. However, 19 989 of these patients had CrCl reported. As a sensitivity analysis, we repeated the primary models in these patients to determine whether the qualitative findings were consistent independent of the measure of RF at listing.
Results
Primary analyses included
Study population
Of the 37 086 kidney transplant candidates in the study population, 43% were female, 65% were Caucasian, 18% were African American, 14% had had a prior kidney transplant, 26% had diabetes as a primary diagnosis and 67% had primary commercial insurance (Table 1) .
A transplant was received by 46% (n = 17 053) of the population, 47% (n = 8041) from a deceased donor and 53% (n = 9012) from a living donor. Of the transplants, 51% were preemptive. The proportion of preemptive transplants among those who received a living donor transplant was 65% and among those who received a deceased donor transplant was 42%. At the end of the study period, 17 305 candidates were still listed, 1155 candidates had been removed from the wait list and 1573 candidates had died while waitlisted.
eGFR at candidate listing Separate models for preemptive transplant likelihood for deceased and living donors were also constructed. For both deceased and living donors, eGFR at listing was significantly and independently associated with preemptive transplant: AOR for preemptive deceased donor transplant = 1.49 per 5 mL/min (95% CI 1.39-1.59) and AOR for preemptive living donor transplant = 1.54 per 5 mL/ min (95% CI 1.45-1.64). Each model had a nonsignificant result from the Hosmer-Lemeshow test, indicating adequate model fit. Candidate survival Figure 3 shows the Kaplan-Meier survival plots following listing stratified by eGFR 15 mL/min/1.73 m 2 at listing. Patients with eGFR <15 mL/min/1.73 m 2 had significantly reduced survival (P = 0.0002) with a 5% lower survival at 5 years following listing (77% versus 82%).
The independent association of RF at listing with candidate survival was confirmed in the multivariable Cox model. Lower hazard for death was significantly associated with higher eGFR at listing (Table 3) . Additional factors associated with greater risk of death included older age, prior renal or extrarenal transplant, diabetes as a 
Candidate survival: particular patient groups
The survival advantage to a higher listing eGFR varied by patient group. Higher eGFR at listing had a smaller impact on survival in younger patients and non-diabetics and a larger impact in patients >60 years old, particularly diabetics (Table 4) .
Sensitivity analyses
Primary analyses were replicated using CrCl instead of eGFR for patients without listing eGFR available. Results using CrCl were generally consistent with results using eGFR at listing. Patient characteristics associated with higher CrCl at listing were Caucasian race, male gender, prior transplant recipient and region. Preemptive transplant likelihood remained associated with CrCl at listing (AOR = 1.25, 95% CI 1.19-1.31). Candidate survival was associated with levels higher and lower than 15 mL/min (P = 0.004) and higher levels were protective for survival in the multivariable model (AHR = 0.88, 95% CI 0.84-0.93).
Discussion
The main findings of this study are: (1) higher eGFR at preemptive listing among candidates who traditionally have better access to transplant: men, Caucasians and patients with private insurance, (2) greater preemptive renal transplant likelihood for patients with higher listing eGFR and (3) better survival prior to transplant associated with higher eGFR at preemptive listing. This study provides substantial evidence for associations between better candidate outcomes and higher RF at preemptive listing.
Our finding that Caucasians have better RF at listing than other groups is consistent with previous studies [18, 19] . It is striking that even though we found lower mortality in African Americans as compared to Caucasians while waitlisted, African Americans were still less likely than Caucasians to receive a preemptive transplant. Race and insurance type have long been associated with renal and preemptive renal transplant access. Research from the UK suggests that socioeconomic deprivation is additionally associated with a higher rate of acute rejection following renal transplantation. Indeed, income deprivation has been shown to be a significant and independent predictor of graft survival in the UK [20] .
Solutions to disparities remain elusive. Lasting progress requires strategies for every step in the transplant process. Our study adds to the existing literature by identifying socioeconomic disparity at a specific step in the transplant process that has not previously been fully described. Our results emphasize that it is particularly important for African Americans and those without private insurance, as well as caregivers guiding patients through the transplant process, to be well informed about listing patients as early as possible.
We found that candidates who lived closest to a transplant center were listed at a higher eGFR than candidates who lived further from a transplant center. Geographic disparity in transplant access is an emerging concern [21] . Poorer socioeconomic status could make travel a barrier to listing. Patients with fewer resources may have difficulty paying for travel to a transplant center, a hotel room and meals away from home. Our results were independent of patients' zip code-level median income, indicating that patients from higher median income areas were also listed at higher RF levels prior to the initiation of dialysis.
We also found proportionally worse survival in elderly candidates listed at lower eGFR. This finding is particularly relevant as the population of older adults with chronic kidney disease increases [22] . Higher eGFR at preemptive listing may be especially important for higher risk elderly or diabetic patients, who seem to derive a proportionately higher survival benefit from higher eGFR at listing. Our study found candidates who had previously received either a renal or a non-renal transplant were listed at a higher eGFR than those candidates who had never received a solid-organ transplant. This result is consistent with a recent study showing candidates listed for a renal transplant who had had a previous non-renal solid-organ transplant are frequently listed preemptively, likely because of greater access to close follow-up by transplant nephrologists [23] . Similarly, it is likely that candidates with diabetes were prelisted at a higher eGFR because they were more likely to be followed by a nephrologist than candidates who did not have diabetes. As well, RRT is often initiated earlier in diabetics than non-diabetics because of an increased clinical tendency toward volume overload and Type IV renal tubular acidosis. This practice pattern may also contribute to our study's finding of a higher eGFR at listing in diabetics.
It makes sense clinically that candidates with higher RF at listing were more likely to receive a preemptive renal transplant. Depending on the rate of loss of RF, candidates with a higher eGFR were probably listed at an earlier stage in their disease and had more time before RRT became a necessity in which to arrange for and actually receive a preemptive renal transplant. As such, one of the clear benefits of listing at a higher level of RF is the opportunity to avoid initiation of maintenance dialysis. Most importantly, candidates with higher RF at listing were significantly more likely to survive during the interval prior to transplantation when compared to those patients with lower RF at listing. Several studies have shown that longer exposure to dialysis prior to transplant leads to worse patient and graft survival. In the present study, however, eGFR at listing was not associated with post-transplant outcomes despite greater chance of dialysis initiation for candidates listed with lower RF. An open question exists as to whether the benefits associated with higher eGFR at listing both prior to transplantation and post-transplantation are directly associated with less dialysis exposure. Other factors may be receipt of better care by proactive patients or the presence of fewer comorbidities delaying care [24, 25] .
The most important differences between our study and previous studies of candidate eGFR and preemptive transplant outcomes are related to the samples of patients chosen for study. Previous work identified eGFR in samples of patients at the time they received a renal transplant [4] or pre-transplant [5] , but not specifically at preemptive listing. Patient sampling at preemptive transplant instead of at preemptive listing may make assessment of associations between lower eGFR and worse survival problematic. Candidates with worse RF at listing may die receiving a transplant and thus would not be included in an analysis that only sampled patients at the time of preemptive transplant. Longer follow-up time in this study also provides more power to demonstrate associations than previous studies with shorter follow-up times. Our study is the first to show that not only is preemptive listing associated with better outcomes for renal transplant patients but that the level of RF at the time of preemptive listing has significant bearing on patients' outcomes.
There are several limitations to our study. First, this is an observational study. However, an interventional study with randomization to early and late transplant referral would be ethically questionable. Our findings are consistent with a previous observational study, substantiating the result even in the absence of a randomized trial [26] . Next, associations between better survival and higher likelihood of receipt of a preemptive transplant and higher eGFR at listing could be attributed to lead time bias. Patients who are listed with higher eGFR have been identified earlier in the course of their disease, and this leads to improved survival. We report not only that outcomes are better among patients identified earlier in the course of their disease, as defined by eGFR, but also that there are notable differences between those patients identified earlier and those patients identified later in the course of their disease. Also, we chose to limit the primary sample to only those candidates with an eGFR estimate available at the time of listing. However, results based on CrCl, which was routinely available earlier in the study cohort, led to equivalent qualitative results. The values for eGFR in this study were taken from the waitlist form filled out by the transplant center at the time of listing for preemptive transplant. This means that the data used to calculate eGFR was produced by multiple different labs across the country and perhaps even different specific eGFR formulas. Additionally, in clinical practice, there is a wide variation in the level of eGFR at which a particular nephrologist, a group of nephrologists or a transplant center initiates dialysis. This variation would affect whether a candidate was listed for a transplant preemptively and thus would affect whether a candidate was included in our sample of patients. However, it is likely that both these potential sources of bias would tend to dilute any observed effects. The fact that our study found highly significant results despite variation indicates that our findings are fairly robust. Our study finds that characteristics of renal transplant candidates are highly variable relative to level of RF at listing and that the patient characteristics associated with higher RF at listing suggest differences in access to care. We also show associations between higher level of RF at listing and higher likelihood of preemptive transplant and better candidate survival. Our study provides further evidence that patients who have the economic wherewithal and the social capital to navigate the processes needed to acquire a transplant are placed at a significant advantage for long-term outcomes. It is difficult to know how to meaningfully address the health care disparities related to renal transplantation and socioeconomic factors found in this analysis and other studies. At the very least, as the health care debate continues, it makes sense for the nephrology community to understand and document these disparities as carefully and accurately as possible. Our results suggest that efforts to facilitate listing of all patients as early as possible in the course of their disease are critical. Conflict of interest statement. None declared.
